Literature DB >> 14633868

Identification of new mutations of the HFE, hepcidin, and transferrin receptor 2 genes by denaturing HPLC analysis of individuals with biochemical indications of iron overload.

Giorgio Biasiotto1, Silvana Belloli, Giuseppina Ruggeri, Isabella Zanella, Gianmario Gerardi, Marcella Corrado, Elena Gobbi, Alberto Albertini, Paolo Arosio.   

Abstract

BACKGROUND: Hereditary hemochromatosis is a recessive disorder characterized by iron accumulation in parenchymal cells, followed by organ damage and failure. The disorder is mainly attributable to the C282Y and H63D mutations in the HFE gene, but additional mutations in the HFE, transferrin receptor 2 (TfR2), and hepcidin genes have been reported. The copresence of mutations in different genes may explain the phenotypic heterogeneity of the disorder and its variable penetrance.
METHODS: We used denaturing HPLC (DHPLC) for rapid DNA scanning of the HFE (exons 2, 3, and 4), hepcidin, and TfR2 (exons 2, 4 and 6) genes in a cohort of 657 individuals with altered indicators of iron status.
RESULTS: DHPLC identification of C282Y and H63D HFE alleles was in perfect agreement with the restriction endonuclease assay. Fourteen DNA samples were heterozygous for the HFE S65C mutation. In addition, we found novel mutations: two in HFE (R66C in exon 2 and R224G in exon 4), one in the hepcidin gene (G71D), and one in TfR2 (V22I), plus several intronic or silent substitutions. Six of the seven individuals with hepcidin or TfR2 coding mutations carried also HFE C282Y or S65C mutations.
CONCLUSION: DHPLC is an efficient method for mutational screening for the genes involved in hereditary hemochromatosis and for the study of their copresence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14633868     DOI: 10.1373/clinchem.2003.023440

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  17 in total

1.  Tumor necrosis factor-alpha promoter variants and iron phenotypes in 785 hemochromatosis and iron overload screening (HEIRS) study participants.

Authors:  Ronald T Acton; James C Barton; Catherine Leiendecker-Foster; Christopher Zaun; Christine E McLaren; John H Eckfeldt
Journal:  Blood Cells Mol Dis       Date:  2010-02-23       Impact factor: 3.039

2.  Down-regulation of hepcidin in porphyria cutanea tarda.

Authors:  Richard S Ajioka; John D Phillips; Robert B Weiss; Diane M Dunn; Maria W Smit; Sean C Proll; Michael G Katze; James P Kushner
Journal:  Blood       Date:  2008-09-22       Impact factor: 22.113

3.  Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6.

Authors:  Jaroslav Truksa; Hongfan Peng; Pauline Lee; Ernest Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-26       Impact factor: 11.205

4.  The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study.

Authors:  Elizabeta Nemeth; Gloria C Preza; Chun-Ling Jung; Jerry Kaplan; Alan J Waring; Tomas Ganz
Journal:  Blood       Date:  2005-09-01       Impact factor: 22.113

Review 5.  Hereditary hemochromatosis and transferrin receptor 2.

Authors:  Juxing Chen; Caroline A Enns
Journal:  Biochim Biophys Acta       Date:  2011-08-16

6.  Transferrin receptor 2: evidence for ligand-induced stabilization and redirection to a recycling pathway.

Authors:  Martha B Johnson; Juxing Chen; Nicholas Murchison; Frank A Green; Caroline A Enns
Journal:  Mol Biol Cell       Date:  2006-12-20       Impact factor: 4.138

7.  Clinical penetrance of C282Y homozygous HFE haemochromatosis.

Authors:  Enrico Rossi; Gary P Jeffrey
Journal:  Clin Biochem Rev       Date:  2004-08

8.  A novel rat model of hereditary hemochromatosis due to a mutation in transferrin receptor 2.

Authors:  Thomas B Bartnikas; Sheryl J Wildt; Amy E Wineinger; Klaus Schmitz-Abe; Kyriacos Markianos; Dale M Cooper; Mark D Fleming
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

Review 9.  Non-HFE haemochromatosis.

Authors:  Daniel-F Wallace; V-Nathan Subramaniam
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

Review 10.  Recent advances in understanding haemochromatosis: a transition state.

Authors:  K J H Robson; A T Merryweather-Clarke; E Cadet; V Viprakasit; M G Zaahl; J J Pointon; D J Weatherall; J Rochette
Journal:  J Med Genet       Date:  2004-10       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.